The five-year reauthorization of spending for US Department of Agriculture programs Congress passed in 2018 ignited the Food and Drug Administration’s consideration of a regulatory pathway for using hemp in dietary supplements.
It could take the next farm bill, which is on lawmakers’ 2023 to-do list, to extinguish an inferno of disagreement between the FDA and stakeholders in regulated industries over lawful use of